UK Companies House feature
OXFORD IMMUNOTEC GLOBAL LIMITED
Cash
£706
-5.4% vs 2023
Net assets
£144K
-30.1% vs 2023
Employees
0
Average over period
Profit before tax
-£62K
-14,328.4% vs 2023
Profile
- Company number
- 08654254
- Status
- Active
- Incorporation
- 2013-08-16
- Last accounts made up
- 2024-12-29
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Net assets
2-year trend · vs UK Healthcare median
Accounts
2-year trend · latest 2023-12-31
| Metric | Trend | 2023-01-01 | 2023-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£199 | -£2,284 | |
| Profit before tax | £436 | -£62,036 | |
| Net profit | — | — | |
| Cash | £746 | £706 | |
| Total assets less current liabilities | £206,136 | £144,098 | |
| Net assets | £206,108 | £144,070 | |
| Equity | £206,108 | £144,070 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having taken into account the above factors, including the re-organisation as discussed in Note 5 "Investments" our directors have a reasonable expectation that we have adequate resources to continue in businessat least 12 months from the date of the financial statements. Accordingly, the financial statements have been prepared on the going concern basis.”
Subsidiaries
- Oxford Immunotec Limited · 100% held · UK · Medical Diagnostics
- Oxford Immunotec USA Inc. · 100% held · United States · Medical Diagnostics
- Immunetics, Inc. · 100% held · United States · Medical Diagnostics
- Oxford Immunotec K.K. · 100% held · Japan · Medical Diagnostics
- Boulder Diagnostic Europe GmbH · 100% held · Germany · Medical Diagnostics
- Oxford Immunotec Asia Limited · 100% held · People's Republic of China · Medical Diagnostics
- Oxford Immunotec (Shanghai) Medical Device Co. Ltd. · 100% held · People's Republic of China · Medical Diagnostics
- Oxford Immunotec (Ireland) Limited · 100% held · Republic of Ireland · Medical Diagnostics
- Oxford Diagnostic Laboratories (UK) Limited · 100% held · UK · Medical Diagnostics
Significant events
- “There have been no significant events after the reporting period that would require disclosure.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GOLDBERG, Joel | Director | 2021-03-08 | Feb 1969 | American |
| HART, Steven Christopher | Director | 2024-01-18 | Apr 1975 | British |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KEILEY, Elizabeth | Secretary | 2013-08-16 | 2019-04-12 |
| KIDD, Janet Louise, Ms. | Secretary | 2019-11-18 | 2021-03-17 |
| MCLAUGHLIN, Matthew Thomas Edward | Secretary | 2019-04-13 | 2019-11-17 |
| ANDREWS, Ronald | Director | 2015-11-04 | 2021-03-08 |
| BALTHROP, SR., Patrick | Director | 2016-01-29 | 2021-03-08 |
| KEEFE, Phillip Anthony | Director | 2022-05-27 | 2024-01-18 |
| KLAUSNER, Mark | Director | 2018-03-01 | 2021-03-08 |
| LATHI, Vijay | Director | 2013-08-22 | 2014-06-12 |
| PITCHFORD, Nigel Aaron, Dr | Director | 2013-08-22 | 2015-06-09 |
| RANDALL, Patricia, Ms. | Director | 2014-06-12 | 2021-03-08 |
| ROSENMAN, Herman | Director | 2013-10-30 | 2021-03-08 |
| SANDBERG, Richard Alvin | Director | 2013-08-16 | 2021-03-08 |
| SPOTTS, Steve Liles | Director | 2013-08-22 | 2018-06-19 |
| STEINMETZ, Ludwig Michael | Director | 2013-08-22 | 2014-06-12 |
| STROHMENGER, Rainer Herbert, Dr | Director | 2013-08-22 | 2013-11-27 |
| TOBIN, James, Mr. | Director | 2014-12-01 | 2021-03-08 |
| WALTON, Andrew Scott | Director | 2015-11-04 | 2021-03-08 |
| WRIGHTON-SMITH, Peter James | Director | 2013-08-16 | 2022-05-27 |
| NEW MEDIA SPARK DIRECTORS LIMITED | Corporate Director | 2013-08-22 | 2013-11-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Revvity (Uk) Holdings Limited | Corporate entity | Shares 75–100% | 2021-03-07 | Active |
Filing timeline
Last 20 of 157 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-07 | AA | accounts | accounts with accounts type full |
| 2025-09-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-03-07 | AAMD | accounts | accounts amended with accounts type full |
| 2025-02-27 | AA | accounts | accounts with accounts type total exemption full |
| 2024-11-05 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-10-10 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-10-10 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-10-10 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-10-10 | RP04CS01 | confirmation-statement | second filing of confirmation statement with made up date |
| 2024-08-22 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-02-15 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2024-02-06 | AA | accounts | accounts with accounts type full |
| 2024-01-18 | AP01 | officers | appoint person director company with name date |
| 2024-01-18 | TM01 | officers | termination director company with name termination date |
| 2023-08-14 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-01-06 | AA | accounts | accounts with accounts type full |
| 2022-08-19 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-08-19 | AD04 | address | move registers to registered office company with new address |
| 2022-06-20 | AD01 | address | change registered office address company with date old address new address |
| 2022-06-13 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ (private-firm) · reference 2023-12-31
5406.44
SAFE
Altman Z″
- Working capital / Total assets 0.598 × 6.56 = +3.92
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets -0.016 × 6.72 = -0.11
- Book equity / Total liabilities 5145.357 × 1.05 = +5402.63
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory